Medindia

X

Rapid Uptake of Targeted Agents Will Drive the Gastric Cancer Drug Market to More Than Double to $1.5 Billion by 2019

Monday, June 21, 2010 General News J E 4
Advertisement
Herceptin's Approval Marks the Beginning of a New Era of Targeted Treatment for Gastric Cancer, According to Findings from Decision Resources

For more information, contact:

Decision Resources, Inc.

Christopher Comfort

781-296-2597

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
'Life Goes Strong' Launches Health Vertical for th...
S
Basketball Fan Affected With Brain Tumor to Shoot ...